Impact of pretransplant donor HBsAb titers
Of the 110 patients, 72 patients (Group A, 65.5%, 72/110) received
grafts from HBsAb-positive donors, and 38 patients (Group B, 34.5%,
38/110) received grafts from HBsAb-negative donors. There was no
significant difference between patients in groups A and B in the levels
of HBsAb at 1 month (P =0.278), 3 months (P =0.307) and 6
months (P =0.282) after transplantation or in the negative
conversion rate of HBsAb within one year after transplantation
(P =0.059).